Page last updated: 2024-12-06

moprolol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

moprolol: (-)-moprolol is beta-blocker & anti-hypertensive agent; (+)-moprolol is inactive; SD 1601 refers to HCl; RN given refers to parent cpd without isomeric designation; structure in Negwer, 5th ed, #6316 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID71213
CHEMBL ID156901
CHEBI ID134974
SCHEMBL ID80724
MeSH IDM0055137

Synonyms (37)

Synonym
(+-)-moprolol
moprolol
CHEBI:134974
CHEMBL156901
1-(2-methoxyphenoxy)-3-(propan-2-ylamino)propan-2-ol
AKOS005254328
5741-22-0
dl-moprolol
moprololum [inn-latin]
moprololum
a94hch4225 ,
1-(isopropylamino)-3-(o-methoxyphenoxy)-2-propanol
einecs 227-254-7
unii-a94hch4225
moprolol [inn]
1-(2-methoxyphenoxy)-3-((1-methylethyl)amino)-2-propanol
[2-hydroxy-3-(2-methoxyphenoxy)propyl](propan-2-yl)amine
moprolol [who-dd]
moprolol [mi]
SCHEMBL80724
MLS006011700
smr004703428
(+/-)-moprolol
LFTFGCDECFPSQD-UHFFFAOYSA-N
1-(isopropylamino)-3-(2-methoxyphenoxy)propan-2-ol
STL488508
2-propanol, 1-(2-methoxyphenoxy)-3-[(1-methylethyl)amino]-
Q15634009
DTXSID00863612
BRD-A51747092-003-01-4
BBL100082
mfcd00864582
(+/-)-moprolol; dl-moprolol
()-moprolol; dl-moprolol
1-(2-methoxyphenoxy)-3-[(propan-2-yl)amino]propan-2-ol
CS-0028195
HY-108306

Research Excerpts

Overview

Levomoprolol is a beta-blocking agent used in the topical treatment of glaucoma.

ExcerptReferenceRelevance
"Levomoprolol is a beta-blocking agent used in the topical treatment of glaucoma. "( Determination by coupled high-performance liquid chromatography-gas chromatography of the beta-blocker levomoprolol in plasma following ophthalmic administration.
Brenn, E; Figini, G; Gazzaniga, A; Gianesello, V, 1989
)
1.05
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
methoxybenzenesAny aromatic ether that consists of a benzene skeleton substituted with one or more methoxy groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (64.29)18.7374
1990's3 (21.43)18.2507
2000's1 (7.14)29.6817
2010's1 (7.14)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 123.42

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index123.42 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index4.25 (4.65)
Search Engine Demand Index224.43 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (123.42)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (17.65%)5.53%
Reviews1 (5.88%)6.00%
Case Studies1 (5.88%)4.05%
Observational0 (0.00%)0.25%
Other12 (70.59%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]